Israeli Supreme Court Directs Sun Pharma To Extend Tender Offer Deadline For Taro
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Sun Pharmaceutical has extended the last date of its tender offer for purchase of outstanding ordinary shares of Taro to Oct. 3, from the previously fixed date of Sept. 3. Sun had to extend the last date to comply with an order by the Supreme Court of Israel temporarily prohibiting the closing of the offer. The tender offer will be valid until the new date unless further extended or earlier terminated
You may also be interested in...
Taro’s Merger Proposal At $15 A Share “Outrageous,” Sun Says; Extends Offer Deadline
MUMBAI - The war of words between Sun Pharmaceutical and Israeli drug maker Taro has intensified as the two companies exchange proposals and counter-proposals for a merger as directed by Israel's Supreme Court
Taro’s Merger Proposal At $15 A Share “Outrageous,” Sun Says; Extends Offer Deadline
MUMBAI - The war of words between Sun Pharmaceutical and Israeli drug maker Taro has intensified as the two companies exchange proposals and counter-proposals for a merger as directed by Israel's Supreme Court
India’s Sun Pharma Hunts For Bargains Amidst Financial Crisis
NEW DELHI - India's Sun Pharmaceutical reported a 135 percent jump in second-quarter net profit as it said it was eyeing more acquisition possibilities with the global financial crisis making valuations of generic companies more attractive